Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 31756773

Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Genes Chromosomes Cancer
Publication date
2020 May
First author
Amoroso L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Amoroso L
      type
      Author
    2. name
      Ognibene M
      type
      Author
    3. name
      Morini M
      type
      Author
    4. name
      Conte M
      type
      Author
    5. name
      Di Cataldo A
      type
      Author
    6. name
      Tondo A
      type
      Author
    7. name
      D'Angelo P
      type
      Author
    8. name
      Castellano A
      type
      Author
    9. name
      Garaventa A
      type
      Author
    10. name
      Lasorsa VA
      type
      Author
    11. name
      Podestà M
      type
      Author
    12. name
      Capasso M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Amoroso L
      type
      Author
    2. name
      Ognibene M
      type
      Author
    3. name
      Morini M
      type
      Author
    4. name
      Conte M
      type
      Author
    5. name
      Di Cataldo A
      type
      Author
    6. name
      Tondo A
      type
      Author
    7. name
      D'Angelo P
      type
      Author
    8. name
      Castellano A
      type
      Author
    9. name
      Garaventa A
      type
      Author
    10. name
      Lasorsa VA
      type
      Author
    11. name
      Podestà M
      type
      Author
    12. name
      Capasso M
      type
      Author
    bibliography ids
    1. nci-bib-0108996206ac690f3ce75a6e
    book metadata
    content sha256
    b0daa1cb2f5f94b986ab35e7de43fb98396475a61a1b45ebc0625f043259c8ac
    document type
    citation
    dois
    1. 10.1002/gcc.22827
    electronic publication date
    display
    2019 Dec 3
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31756773
    immutable id
    pubmed:31756773@b0daa1cb2f5f94b986ab35e7de43fb98396475a61a1b45ebc0625f043259c8ac
    journal
    abbreviation
    Genes Chromosomes Cancer
    issn electronic
    1098-2264
    issn print
    1045-2257
    issue
    5
    name
    Genes, chromosomes & cancer
    nlm unique id
    9007329
    pages
    277-285
    volume
    59
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31756773
      provenance
      batch id
      4c5003fbb78890e89ae1
      provider
      NCBI PubMed ESummary
      record sha256
      e2767a35f5444a2c82292637350fa8822dce8e8fd249378866b8e64480fa9e10
      response sha256
      890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
      retrieved at
      2026-09-09T23:47:48.270700+00:00
      publication date
      display
      2020 May
      precision
      month
      year
      2020
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31756773/
      title
      Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.

      Preserved source evidence · Independent clinical review pending · Not medical advice